Re: http://libgen.org/sc...3.268680&open=1
Quote : our results suggest a pivotal role of mitochondria-related signalling and mtROS in modulating endothelial function with age. This possibility is further supported by previous studies showing a life-extending effect of endothelial cell-specific knockout of p66SHC, a signalling protein involved in sensing and regulation of mtROS production (Camici et al. 2007; Gertz & Steegborn, 2010). We observed a marked elevation in phosphorylation of p66SHC, an indication of its activation (Gertz & Steegborn, 2010), in the arteries of old compared with young mice, and this was accompanied by increased vascular mitochondrial superoxide production. MitoQ normalized p66SHC activation and reduced mitochondrial superoxide production, suggesting that an increase in mtROS-mediated vascular oxidative stress may be a key mechanism contributing to the age-related decline in endothelial function.
This is interesting. How would that dosing relate to humans though? The mice certainly received more than the human equivalent of 10 mg !
I hope that someone performs legitimate longevity studies on wild type mice using MitoQ
We have funding for a human studies on this work early next year - watch this space.
Longevity studies are being considered for funding also. All going well we will have that confirmed by the end of this year.
Thanks
Greg